-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on United Therapeutics, Lowers Price Target to $613

Benzinga·07/10/2026 18:06:47
Listen to the news
B of A Securities analyst Greg Harrison maintains United Therapeutics (NASDAQ:UTHR) with a Neutral and lowers the price target from $620 to $613.